Electrophysiological challenges of cell-based myocardial repair
- PMID: 20008740
- PMCID: PMC3293934
- DOI: 10.1161/CIRCULATIONAHA.107.751412
Electrophysiological challenges of cell-based myocardial repair
Figures




Similar articles
-
Potential Strategies for Clinical Translation of Repeated Cell Therapy.Circ Res. 2019 Mar;124(5):690-692. doi: 10.1161/CIRCRESAHA.118.314653. Circ Res. 2019. PMID: 30817255 Free PMC article.
-
Cardiomyocyte maturation: It takes a village to raise a kid.J Mol Cell Cardiol. 2014 Sep;74:193-5. doi: 10.1016/j.yjmcc.2014.05.012. Epub 2014 May 27. J Mol Cell Cardiol. 2014. PMID: 24874422 Free PMC article. No abstract available.
-
Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.Trends Cardiovasc Med. 2016 Nov;26(8):663-672. doi: 10.1016/j.tcm.2016.05.001. Epub 2016 May 11. Trends Cardiovasc Med. 2016. PMID: 27296521 Review.
-
Regenerative Therapy for Cardiomyopathies.J Cardiovasc Transl Res. 2018 Oct;11(5):357-365. doi: 10.1007/s12265-018-9807-z. Epub 2018 May 9. J Cardiovasc Transl Res. 2018. PMID: 29744805 Free PMC article. Review.
-
Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.Trends Cardiovasc Med. 2021 Feb;31(2):85-90. doi: 10.1016/j.tcm.2020.01.002. Epub 2020 Jan 14. Trends Cardiovasc Med. 2021. PMID: 31983535 Review.
Cited by
-
Human ex-vivo action potential model for pro-arrhythmia risk assessment.J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:183-95. doi: 10.1016/j.vascn.2016.05.016. Epub 2016 May 25. J Pharmacol Toxicol Methods. 2016. PMID: 27235787 Free PMC article.
-
Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.J Cardiovasc Transl Res. 2018 Oct;11(5):375-392. doi: 10.1007/s12265-018-9801-5. Epub 2018 Mar 19. J Cardiovasc Transl Res. 2018. PMID: 29557052 Review.
-
Intracoronary delivery of mesenchymal stem cells reduces proarrhythmogenic risks in swine with myocardial infarction.Ir J Med Sci. 2011 Jun;180(2):379-85. doi: 10.1007/s11845-011-0687-3. Epub 2011 Feb 1. Ir J Med Sci. 2011. PMID: 21286844
-
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues.Stem Cell Res Ther. 2019 Dec 4;10(1):373. doi: 10.1186/s13287-019-1486-4. Stem Cell Res Ther. 2019. PMID: 31801634 Free PMC article.
-
Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.Stem Cell Res Ther. 2019 Mar 29;10(1):113. doi: 10.1186/s13287-019-1205-1. Stem Cell Res Ther. 2019. PMID: 30925936 Free PMC article.
References
-
- National Institutes of Health, National Heart, Lung, and Blood Institute. Fact Book Fiscal Year 2005. Bethesda, Md: National Institutes of Health; 2006.
-
- Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol. 2008;28:208–16. - PubMed
-
- Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol. 2006;47:1777–85. - PubMed
-
- Boyle AJ, Schulman SP, Hare JM, Oettgen P. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation. 2006;114:339–52. - PubMed
-
- Oettgen P, Boyle AJ, Schulman SP, Hare JM. Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring. Circulation. 2006;114:353–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical